Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes

scientific article published on 01 September 2007

Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.7326/0003-4819-147-5-200709040-00005
P698PubMed publication ID17785485

P50authorKeith FoxQ72227369
Susan ChrolaviciusQ82040593
Jean-Pierre BassandQ82062172
Shamir MehtaQ87398837
Pierre TherouxQ114292241
Vicent ValentinQ114453051
OASIS 5 InvestigatorsQ114775439
Leopoldo Soares-PiegasQ114775444
Salim YusufQ2214381
Lars WallentinQ6230815
P2093author name stringTiziano Moccetti
Rizwan Afzal
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectacute coronary syndromeQ266018
P304page(s)304-310
P577publication date2007-09-01
P1433published inAnnals of Internal MedicineQ564416
P1476titleInfluence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes
P478volume147